AST-1306

AST-1306 Struktur
897383-62-9
CAS-Nr.
897383-62-9
Englisch Name:
AST-1306
Synonyma:
CS-590;ALS 1306;AST-1306;Allitinib;Allitinib (AST1306);N-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)acrylamide;N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide;N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide;2-Propenamide, N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-;anilino-quinazoline,Inhibitor,anti-cancer,Epidermal growth factor receptor,ALS1306,Allitinib,Irreversible,HER1,inhibit,AST1306,AST 1306,ALS-1306,ErbB-1,EGFR
CBNumber:
CB82620006
Summenformel:
C24H18ClFN4O2
Molgewicht:
448.88
MOL-Datei:
897383-62-9.mol

AST-1306 Eigenschaften

Siedepunkt:
655℃
Dichte
1.395
Flammpunkt:
350℃
storage temp. 
Store at -20°C
Löslichkeit
≥22.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
Aggregatzustand
solid
pka
12.16±0.43(Predicted)

Sicherheit

AST-1306 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

AST-1306 is a novel irreversible inhibitor of EGFR and ErbB4 with IC50 of 0.5 nM and 0.8 nM, respectively.

AST-1306 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


AST-1306 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 85)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32715 60
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
Hebei Duling International Trade Co. LTD
+8617333973358
sales01@hbduling.cn China 15619 58
LEAP CHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 24738 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3136 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58

  • AST-1306
  • ALS 1306
  • N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide
  • N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide
  • Allitinib (AST1306)
  • Allitinib
  • CS-590
  • N-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)acrylamide
  • 2-Propenamide, N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-
  • anilino-quinazoline,Inhibitor,anti-cancer,Epidermal growth factor receptor,ALS1306,Allitinib,Irreversible,HER1,inhibit,AST1306,AST 1306,ALS-1306,ErbB-1,EGFR
  • 897383-62-9
Copyright 2019 © ChemicalBook. All rights reserved